Top

Published in:

28-06-2022 | Adenovirus | Review

Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management

Author: Philippe Caron

Published in: Endocrine | Issue 3/2022

Abstract

Since the Covid-19 pandemic emerged in 2019, several adenoviral-vectored, mRNA-based and inactivated whole-virus vaccines have been developed. A massive vaccination campaign has been undertaken around the world, and an increasing number of SARS-CoV-2 vaccine-induced thyroid diseases have been described in the literature. Subacute thyroiditis has been reported in 52 patients, mean age 45.5 ± 1.8 years, mainly in women (n = 39). Graves’ disease is more frequent in women (n = 22) than in men (n = 10), mean age 46.2 ± 2.6 years, reported as new onset, recurrent or exacerbation of well-controlled hyperthyroidism. The mean time to symptoms onset is 9.0 ± 0.8 days in subacute thyroiditis, and 15.1 ± 2.6 days in Graves’ patients. Rare patients (n = 6) present silent or painless autoimmune thyroiditis. Thyroid function and autoimmune tests, inflammatory markers, thyroid echography with colour flow Doppler, radio-activity uptake on thyroid scan, medical treatment and follow-up are described and compared in patients with SARS-CoV-2 vaccine-induced thyroid diseases. The underlying pathogenic mechanisms of vaccine-induced thyroid diseases, molecular mimicry (various SARS-CoV-2 proteins sharing a genetic homology with a large heptapeptide human protein) or autoimmune/inflammatory syndrome induced by adjuvants (ASIA) are discussed in the context of predisposition or genetic susceptibility. The benefits of SARS-CoV-2 vaccination far outweigh the potential vaccine-induced adverse effects, but clinicians should be aware of possible autoimmune and inflammatory thyroid diseases, and can advise patients to seek medical assistance when experiencing anterior neck pain, fever or palpitations following SARS-CoV-2 vaccines. Further studies are warranted to investigate the etiopathogenesis and to clarify the factors which predispose patients to SARS-CoV-2 vaccine-induced thyroid diseases.

B.G. İremli, S.N. Şendur, U. Ünlütürk, Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: postvaccination ASIA syndrome. J. Clin. Endocrinol. Metab. 106(9), 2600–2605 (2021). https://doi.org/10.1210/clinem/dgab373CrossRefPubMed

S.O. Oyibo, Subacute thyroiditis after receiving the adenovirus-vectored vaccine for coronavirus disease (COVID-19). Cureus 13, e16045 (2021). https://doi.org/10.7759/cureus.16045CrossRefPubMedPubMedCentral

S. Franquemont, J. Juan Galvez, Subacute thyroiditis after mRNA vaccine for Covid‐19. J. Endocr. Soc. 5, A956–A957 (2021). https://doi.org/10.1210/jendso/bvab048.1954CrossRefPubMedCentral

J. Schimmel, E.L. Alba, A. Chen, M. Russell, R. Srinath, Letter to the Editor: thyroiditis and thyrotoxicosis after the SARS-CoV-2 mRNA vaccine. Thyroid 31, 1440 (2021). https://doi.org/10.1089/thy.2021.0184CrossRefPubMed

E.S. Saygılı, E. Karakilic, Subacute thyroiditis after inactive SARS-CoV-2 vaccine. BMJ Case Rep. 14, e244711 (2021). https://doi.org/10.1136/bcr-2021-244711CrossRefPubMedPubMedCentral

E. Sigstad, K.K. Grøholt, O. Westerheim, Subacute thyroiditis after vaccination against SARS-CoV-2. Tidsskr Nor Laegeforen. 2021, 141 (2021-14). https://doi.org/10.4045/tidsskr.21.0554

M.S. Jeeyavudeen, A.W. Patrick, F.W. Gibb, A.R. Dover, COVID-19 vaccine-associated subacute thyroiditis: an unusual suspect for de Quervain’s thyroiditis. BMJ Case Rep. 14, e246425 (2021). https://doi.org/10.1136/bcr-2021-246425CrossRefPubMedPubMedCentral

P. Soltanpoor, G. Norouzi, Subacute thyroiditis following COVID-19 vaccination. Clin. Case Rep. 9, e04812 (2021). https://doi.org/10.1002/ccr3.4812CrossRefPubMedPubMedCentral

G.M. Ratnayake, D. Dworakowska, A.B. Grossman, Can COVID-19 immunisation cause subacute thyroiditis? Clin. Endocrinol. (2021). https://doi.org/10.1111/cen.14555

10.

M. Sözen, Ö. Topaloğlu, B. Çetinarslan, A. Selek, Z. Cantürk, E. Gezer, D. Köksalan, T. Bayraktaroğlu, COVID-19 mRNA vaccine may trigger subacute thyroiditis. Hum. Vaccin. Immunother. 1–6 (2021). https://doi.org/10.1080/21645515.2021.2013083

11.

A. Kyriacou, S. Ioakim, A.A. Syed, COVID-19 vaccination and a severe pain in the neck. Eur. J. Intern. Med. 94, 95–96 (2021). https://doi.org/10.1016/j.ejim.2021.10.008

12.

K.R. Patel, M.E. Cunnane, D.G. Deschler, SARS-CoV-2 vaccine-induced subacute thyroiditis. Am. J. Otolaryngol. 43, 103211 (2022). https://doi.org/10.1016/j.amjoto.2021.103211CrossRefPubMed

13.

M. Şahin Tekin, S. Şaylısoy, G. Yorulmaz, Subacute thyroiditis following COVID-19 vaccination in a 67-year-old male patient: a case report. Hum. Vaccin Immunother. 17, 4090–4092 (2021). https://doi.org/10.1080/21645515.2021.1947102CrossRefPubMedPubMedCentral

14.

C. Bornemann, K. Woyk, C. Bouter, Case report: two cases of subacute thyroiditis following SARS-CoV-2 vaccination. Front Med. 8, 737142 (2021). https://doi.org/10.3389/fmed.2021.737142CrossRef

15.

K.A. Lee, Y.J. Kim, H.Y. Jin, Thyrotoxicosis after COVID-19 vaccination: seven case reports and a literature review. Endocrine 74, 470–472 (2021). https://doi.org/10.1007/s12020-021-02898-5CrossRefPubMedPubMedCentral

16.

A. Siolos, K. Gartzonika, S. Tigas. Metabol Open. Thyroiditis following vaccination against COVID-19: Report of two cases and review of the literature. Metab. Open 12, 100136 (2021). https://doi.org/10.1016/j.metop.2021.100136

17.

A. Pujol, L.A. Gómez, C. Gallegos, J. Nicolau, P. Sanchís, M. González-Freire, Á.A. López-González, K. Dotres, L. Masmiquel, Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves’ disease to silent thyroiditis. J. Endocrinol. Invest. 1–8 (2021). https://doi.org/10.1007/s40618-021-01707-0

18.

M. Pandya, G. Thota, X. Wang, H. Luo. Thyroiditis after coronavirus disease 2019 (COVID-19) mRNA vaccine: a case series. AACE Clin. Case Rep. (2021). https://doi.org/10.1016/j.aace.2021.12.002

19.

B. Pla Peris, A.Á. Merchante Alfaro, F.J. Maravall Royo, P. Abellán Galiana, S. Pérez Naranjo, M. González Boillos, Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion. J Endocrinol. Invest. 1–7 (2022). https://doi.org/10.1007/s40618-022-01739-0

20.

L. Das, S.K. Bhadada, A. Sood, Post-COVID-vaccine autoimmune/inflammatory syndrome in response to adjuvants (ASIA syndrome) manifesting as subacute thyroiditis. J. Endocrinol. Invest. 45, 465–467 (2022). https://doi.org/10.1007/s40618-021-01681-7CrossRefPubMed

21.

L.M. Raven, A.I. McCormack, J.R. Greenfield, Letter to the Editor from Raven: three cases of subacute thyroiditis following SARS-CoV-2 vaccine. J Clin Endocrinol Metab. dgab822 (2021). https://doi.org/10.1210/clinem/dgab822.

22.

S. Chatzi, A. Karampela, C. Spiliopoulou, G. Boutzios, Subacute thyroiditis after SARS-CoV-2 vaccination: a report of two sisters and summary of the literature. Hormones 21, 177–179 (2022). https://doi.org/10.1007/s42000-021-00332-z.CrossRefPubMed

23.

S.H. Oğuz, S.N. Şendur, B.G. İremli, A. Gürlek, T. Erbas, U. Ünlütürk, SARS-CoV-2 vaccine-induced thyroiditis: safety of Re-vaccinations and Clinical Follow-up. J. Clin. Endocrinol. Metab. dgac049 (2022). https://doi.org/10.1210/clinem/dgac049

24.

O. Vera-Lastra, A. Ordinola Navarro, M.P. Cruz Domiguez, G. Medina, T.I. Sánchez Valadez, L.J. Jara, Two cases of Graves’ disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. Thyroid 31, 1436–1439 (2021). https://doi.org/10.1089/thy.2021.0142CrossRefPubMed

25.

G. Zettinig, M. Krebs, Two further cases of Graves’ disease following SARS-Cov-2 vaccination. J. Endocrinol. Invest. 45, 227–228 (2022). https://doi.org/10.1007/s40618-021-01650-0CrossRefPubMed

26.

C. Sriphrapradang, P.C. Shantavasinkul, Graves’ disease following SARS-CoV-2 vaccination. Endocrine 74, 473–474 (2021). https://doi.org/10.1007/s12020-021-02902-yCrossRefPubMedPubMedCentral

27.

T.J. Goblirsch, A.E. Paulson, G. Tashko, A.J. Mekonnen, Graves’ disease following administration of second dose of SARS-CoV-2 vaccine. BMJ Case Rep. 14, e246432 (2021). https://doi.org/10.1136/bcr-2021-246432CrossRefPubMedPubMedCentral

28.

W. Hamouche, Y. El Soufi, S. Alzaraq, B.V. Okafor, F. Zhang, C. Paras, A case report of new onset graves’ disease induced by SARS-CoV-2 infection or vaccine? J. Clin. Transl. Endocrinol. Case Rep. 23, 100104 (2022). https://doi.org/10.1016/j.jecr.2021.100104CrossRefPubMed

29.

D.T.W. Lui, K.K. Lee, C.H. Lee, A.C.H. Lee, I.F.N. Hung, K.C.B. Tan, Development of Graves’ disease after SARS-CoV-2 mRNA vaccination: a case report and literature review. Front. Public Health 9, 778964 (2021). https://doi.org/10.3389/fpubh.2021.778964CrossRefPubMedPubMedCentral

30.

A. Patrizio, S.M. Ferrari, A. Antonelli, P. Fallahi, A case of Graves’ disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination. J. Autoimmun. 125, 102738 (2021). https://doi.org/10.1016/j.jaut.2021.102738CrossRefPubMedPubMedCentral

31.

C. Sriphrapradang, Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease. Endocrine 74, 226–227 (2021). https://doi.org/10.1007/s12020-021-02879-8.CrossRefPubMedPubMedCentral

32.

G. Pierman, E. Delgrange, C. Jonas, Recurrence of Graves’ disease (a Th1-type Cytokine Disease) following SARS-CoV-2 mRNA vaccine administration: a simple coincidence? Eur. J. Case Rep. Intern Med. 8, 002807 (2021). https://doi.org/10.12890/2021_002807CrossRefPubMedPubMedCentral

33.

K. Yamamoto, T. Mashiba, K. Takano, T. Suzuki, M. Kami, M. Takita, E. Kusumi, Y. Mizuno, T. Hamaki, A case of exacerbation of subclinical hyperthyroidism after first administration of BNT162b2 mRNA COVID-19 vaccine. Vaccines 9, 1108 (2021). https://doi.org/10.3390/vaccines9101108CrossRefPubMedPubMedCentral

34.

L. di Filippo, L. Castellino, A. Giustina, Occurrence and response to treatment of Graves’ disease after COVID vaccination in two male patients. Endocrine 75, 19–21 (2022). https://doi.org/10.1007/s12020-021-02919-3.CrossRefPubMed

35.

M.A. Weintraub, B. Ameer, N. Sinha Gregory, Graves disease following the SARS-CoV-2 vaccine: case series. J. Investig. Med. High. Impact Case Rep. 9, 23247096211063356 (2021). https://doi.org/10.1177/23247096211063356CrossRefPubMedPubMedCentral

36.

H.M. Leber, L. Sant’Ana, N.R. Konichi da Silva, M.C. Raio, T.J.M.M. Mazzeo, C.M. Endo, H. Nascimento, C.E. de Souza, Acute thyroiditis and bilateral optic neuritis following SARS-CoV-2 vaccination with CoronaVac: a case report. Ocul. Immunol. Inflamm. 29, 1200–1206 (2021). https://doi.org/10.1080/09273948.2021.1961815CrossRefPubMed

37.

M. Capezzone, M. Tosti-Balducci, E.M. Morabito, G.P. Caldarelli, A. Sagnella, S. Cantara, M. Alessandri, M.G. Castagna, Silent thyroiditis following vaccination against COVID-19: report of two cases. J Endocrinol Invest. 1–5, (2022). https://doi.org/10.1007/s40618-021-01725-y

38.

L. Mukhopadhyay, P.D. Yadav, N. Gupta, S. Mohandas, D.Y. Patil, A. Shete-Aich, S. Panda, B. Bhargava, Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates. Indian J. Med. Res. 153, 93–114 (2021). https://doi.org/10.4103/ijmr.IJMR_4431_20CrossRefPubMedPubMedCentral

39.

Y.H. Chin, C.H. Ng, M.H. Lee, J.W.H. Koh, J. Kiew, S.P. Yang et al. Prevalence of thyroid eye disease in Graves’ disease: a meta-analysis and systematic review. Clin. Endocrinol. 93(4), 363–74 (2020)CrossRef

40.

T.J. Rubinstein, Thyroid Eye Disease Following COVID-19 vaccine in a patient with a history Graves’ disease: a case report. Ophthalmic Plast. Reconstr. Surg. 37, e221–e223 (2021). https://doi.org/10.1097/IOP.0000000000002059CrossRefPubMedPubMedCentral

41.

F. Fang, S. Yan, L. Zhao, Y. Jin, Y. Wang, Concurrent onset of subacute thyroiditis and Graves׳ disease. Am. J. Med Sci. 352, 224–6 (2016). https://doi.org/10.1016/j.amjms.2016.04.009CrossRefPubMed

42.

T.D. Hoang, V.Q. Mai, P.W. Clyde, M.K. Shakir, Simultaneous occurrence of subacute thyroiditis and Graves’ disease. Thyroid 21, 1397–400 (2011). https://doi.org/10.1089/thy.2011.0254CrossRefPubMed

43.

A. Vojdani, E. Vojdani, D. Kharrazian, Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol. 11, 617089 (2021). https://doi.org/10.3389/fimmu.2020.617089CrossRefPubMedPubMedCentral

44.

Y. Shoenfeld, N. Agmon-Levin, ‘ASIA’ - autoimmune/inflammatory syndrome induced by adjuvants. J. Autoimmun. 36, 4–8 (2011). https://doi.org/10.1016/j.jaut.2010.07.003CrossRefPubMed

45.

N.L. Bragazzi, A. Hejly, A. Watad, M. Adawi, H. Amital, Y. Shoenfeld, ASIA syndrome and endocrine autoimmune disorders. Best. Pr. Res Clin. Endocrinol. Metab. 34, 101412 (2020). https://doi.org/10.1016/j.beem.2020.101412.CrossRef

46.

A. Passah, S. Arora, N.A. Damle, K.S. Reddy, D. Khandelwal, S. Aggarwal, Occurrence of subacute thyroiditis following influenza vaccination. Indian J. Endocrinol. Metab. 22, 713–714 (2018). https://doi.org/10.4103/ijem.IJEM_237_18CrossRefPubMedPubMedCentral

47.

J.Y. Hsiao, S.C. Hsin, M.C. Hsieh, P.J. Hsia, S.J. Shin, Subacute thyroiditis following influenza vaccine (Vaxigrip) in a young female. Kaohsiung J. Med. Sci. 22, 297–300 (2006). https://doi.org/10.1016/s1607-551x(09)70315-8CrossRefPubMed

48.

C.M. Girgis, R.R. Russo, K. Benson, Subacute thyroiditis following the H1N1 vaccine. J. Endocrinol. Invest. 33, 506 (2010). https://doi.org/10.1007/BF03346633CrossRefPubMed

49.

J. Toft, S. Larsen, H. Toft, Subacute thyroiditis after hepatitis B vaccination. Endocr. J. 45, 135 (1998)PubMed

50.

P. Pellegrino, V. Perrone, M. Pozzi, C. Carnovale, C. Perrotta, E. Clementi, S. Radice, The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems. Immunol. Res. 61, 90–6 (2015). https://doi.org/10.1007/s12026-014-8567-3CrossRefPubMed

51.

T.J. Smith, L. Hegedüs, Graves’ disease. N. Engl. J. Med. 375, 1552–1565 (2016)CrossRefPubMed

52.

T.F. Davies, S. Andersen, R. Latif, Y. Nagayama, G. Barbesino, M. Brito, A.K. Eckstein, A. Stagnaro-Green, G.J. Kahaly, Graves’ disease. Nat. Rev. Dis. Prim. 6, 52 (2020). https://doi.org/10.1038/s41572-020-0184-yCrossRefPubMed

53.

M. Stasiak, B. Tymoniuk, R. Michalak, B. Stasiak, M.L. Kowalski, A. Lewiński, Subacute thyroiditis is associated with HLA-B*18:01, -DRB1*01 and -C*04:01-the significance of the new molecular background. J. Clin. Med. 9, 534 (2020). https://doi.org/10.3390/jcm9020534CrossRefPubMedCentral

Title: Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management
Author: Philippe Caron
Publication date: 28-06-2022
Publisher: Springer US
Keywords: Adenovirus
Thyroid Disease
Thyroid Disease
Vaccination
Subacute Granulomatous Thyroiditis
Hyperthyroidism
SARS-CoV-2
Thyrotoxicosis
Thyroiditis
Methimazole
Published in: Endocrine / Issue 3/2022
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-022-03118-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2022

Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes

Accuracy of the intermittently scanned continuous glucose monitoring system in critically ill patients: a prospective, multicenter, observational study

Identification of the collagen family as prognostic biomarkers in papillary thyroid carcinoma

Pregnancy after pituitary surgery does not influence the recurrence of Cushing’s disease

Cortex or cancellous—which is early for the decrease of bone content for vertebral body in health?

The association between Takotsubo cardiomyopathy and thyrotoxicosis: A systematic review

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage